Literature DB >> 29282903

Nanocarrier-Mediated Photochemotherapy and Photoradiotherapy.

Antonia G Denkova1, Robine M de Kruijff1, Pablo Serra-Crespo1.   

Abstract

Photothermal therapy (PTT) and photodynamic therapy (PDT) both utilize light to induce a therapeutic effect. These therapies are rapidly gaining importance due to the noninvasiveness of light and the limited adverse effect associated with these treatments. However, most preclinical studies show that complete elimination of tumors is rarely observed. Combining PDT and PTT with chemotherapy or radiotherapy can improve the therapeutic outcome and simultaneously decrease side effects of these conventional treatments. Nanocarriers can help to facilitate such a combined treatment. Here, the most recent advancements in the field of photochemotherapy and photoradiotherapy, in which nanocarriers are employed, are reviewed.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  chemotherapy; combined phototherapies; nanocarriers; radiation therapy

Mesh:

Substances:

Year:  2017        PMID: 29282903     DOI: 10.1002/adhm.201701211

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  10 in total

1.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

2.  Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer.

Authors:  Xiang Li; Qian Zou; Jing Zhang; Peng Zhang; Xiong Zhou; Satya Siva Kishan Yalamarty; Xinli Liang; Yali Liu; Qin Zheng; Jianqing Gao
Journal:  Int J Nanomedicine       Date:  2020-09-11

3.  Photosensitizer-loaded biomimetic platform for multimodal imaging-guided synergistic phototherapy.

Authors:  Ying Tian; Ying Zhao; Wenfei Liu; Ying Liu; Yuxia Tang; Zhaogang Teng; Chunni Zhang; Shouju Wang; Guangming Lu
Journal:  RSC Adv       Date:  2018-09-18       Impact factor: 4.036

Review 4.  Functionalized Carbon Nanostructures Versus Drug Resistance: Promising Scenarios in Cancer Treatment.

Authors:  Manuela Curcio; Annafranca Farfalla; Federica Saletta; Emanuele Valli; Elvira Pantuso; Fiore Pasquale Nicoletta; Francesca Iemma; Orazio Vittorio; Giuseppe Cirillo
Journal:  Molecules       Date:  2020-04-30       Impact factor: 4.411

5.  Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy.

Authors:  Dan Wang; Xuefen Li; Xinfang Li; Anfeng Kang; Linhong Sun; Miao Sun; Feng Yang; Congjian Xu
Journal:  Int J Nanomedicine       Date:  2019-09-18

Review 6.  Recent advances in multifunctional nanomaterials for photothermal-enhanced Fenton-based chemodynamic tumor therapy.

Authors:  Panchanathan Manivasagan; Ara Joe; Hyo-Won Han; Thavasyappan Thambi; Manickam Selvaraj; Kumarappan Chidambaram; Jungbae Kim; Eue-Soon Jang
Journal:  Mater Today Bio       Date:  2022-01-04

7.  Single-molecular phosphorus phthalocyanine-based near-infrared-II nanoagent for photothermal antitumor therapy.

Authors:  Li-Na Zhou; Houhe Pan; Jing-Lan Kan; Qun Guan; Yang Zhou; Yu-Bin Dong
Journal:  RSC Adv       Date:  2020-06-12       Impact factor: 4.036

Review 8.  High Drug-Loading Nanomedicines for Tumor Chemo-Photo Combination Therapy: Advances and Perspectives.

Authors:  Ya Wang; Yujie Zhang; Xiaojiang Zhang; Zhe Zhang; Junjun She; Daocheng Wu; Wei Gao
Journal:  Pharmaceutics       Date:  2022-08-19       Impact factor: 6.525

Review 9.  Nanotechnology for Cancer Therapy Based on Chemotherapy.

Authors:  Chen-Yang Zhao; Rui Cheng; Zhe Yang; Zhong-Min Tian
Journal:  Molecules       Date:  2018-04-04       Impact factor: 4.411

10.  New-generation photosensitizer-anchored gold nanorods for a single near-infrared light-triggered targeted photodynamic-photothermal therapy.

Authors:  Zongjunlin Liu; Fang Xie; Jun Xie; Jianhao Chen; Yang Li; Qin Lin; Fanghong Luo; Jianghua Yan
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.